92 results found.
        
NASS 2015: Interbody Fusion, SI Joint, Robotics Take Spotlight
By Carolyn LaWell While the spine market continues to grow in the low-single-digits, small- to mid-sized pure-play companies remain confident that their data-backed products will keep taking market share from larger, diversified players. That sentiment carried...
BARE BONES® - August 24, 2015
One-year results from use of SI-BONE's iFuse Implant System® in both INSITE (Investigation of Sacroiliac Fusion Treatment) and SIFI (Sacroiliac Joint Fusion with iFuse Implant System) studies demonstrate
Spine and Joint Lead Investor Interest in 1H15
Funds raised in the first half of 2015 show continued interest in support of the spine and joint reconstruction segments: of the $135 million we’ve reported thus far, both claim over 28 percent of the whole. Orthobiologic companies, whose products have application across different segmen...
BARE BONES® - June 1, 2015
The North American Spine Society recommends coverage for percutaneous SI joint fusion when certain criteria are met. The evidence-based coverage policy is based primarily on 19 SI-BONE iFuse® publishe...
BARE BONES® - May 26, 2015
SI-BONE closed a US $21MM round of growth capital financing. Proceeds will support further U.S. and EU expansion in anticipation of increased demand in the growing minimally invasive surgical SI joint fusion market
BARE BONES® - March 24, 2015
SI-BONE was granted U.S. Patent No. 8,986,348, Systems and Methods for the Fusion of the Sacral-Iliac Joint. (
BARE BONES® - March 9, 2015
Prospective, randomized, controlled clinical trial results provided Level 1 evidence that minimally invasive sacroiliac joint fusion with SI-BONE's iFuse Implant System® yielded greater improvements i...
BARE BONES® - March 2, 2015
SI-BONE announced that >15,000 iFuse Implant System® procedures have been performed worldwide to date, using >44,000 iFuse implants. Over 900 surgeons have performed the procedure in the
BARE BONES® - January 5, 2015
Noridian Healthcare commenced reimbursement coverage for MIS SI joint fusion, including use of SI-BONE's iFuse Implant System®, effective 1/1/15. The change enables >9MM Medicare bene...
NASS Recap: Product Updates and Highlights
Despite continual challenges regarding regulatory clearance, reimbursement and market penetration, sentiment from manufacturers at the North American Spine Society (NASS) meeting in San Francisco indicated that the spine market is stabilizing and presenting greater opportunities than in recent...
You're Invited: The State and Future of the Orthopaedic Industry™ Symposium
Dear Members, You didn’t need to read our sur...
BARE BONES® - October 27, 2014
Study results support long-term durability of positive clinical outcomes following the use of SI-BONE's iFuse Implant System® in minimally invasive sacroiliac joint fusion. Clinical improveme...
BARE BONES® - September 24, 2014
SI-BONE was awarded U.S. Patent No. 8,840,651, covering a threaded, fenestrated implant with a tapered distal end that may be placed from one bone across a joint into another bone. Specificall...
BARE BONES® - September 24, 2014
SI-BONE, manufacturer of the iFuse Implant System®, noted that the American Medical Association has published its Category I CPT code 27279 for minimally invasive surgical (MIS) sacro...
BARE BONES® - August 21, 2014
Priority Health of Michigan updated its Lumbar Fusion Medical Policy No. 91590-R4 providing positive coverage for SI-BONE's MIS SI joint fusion procedure that employs the iFuse Implant System
Investors Focused on Growth-stage Companies vs. New Technologies
Large, cash-rich orthopaedic device companies have increasingly opted to acquire companies and product lines that allow for scale over focusing resources on in-house development. The investor community has followed a similar trend, backing growth-stage companies with regulatory cleared produ...
BARE BONES® - May 12, 2014
SI-BONE announced that Medicare Novitas will begin covering MIS SI joint fusion on a case-by-case basis, including use of the iFuse Implant System®. Specifically, Novitas has removed the CPT...
BARE BONES® - April 28, 2014
SI-BONE completed a US $33MM growth capital round of financing. Funds will support U.S. sales expansion, ex-U.S. commercialization (in Australia, New Zealand and Hong Kong), R&D, medical affairs, regulatory (including Asia, Mi...
BARE BONES® - March 6, 2014
SI-BONE, manufacturer of the iFuse Implant System®, noted that the American Medical Association has voted to establish a Category I CPT Code for percutaneous/minimally invasive sacroiliac joint arthrodesis, e...
BARE BONES® - February 25, 2014
SI-BONE announced that the Medicare Administrative Contractor Palmetto GBA will begin covering MIS SI joint fusion, including when performed using the iFuse Implant System®, on a case-by-case basis. Palmetto has removed
BARE BONES® - January 6, 2014
SI-BONE's iFuse Implant System® has been used in >10,000 procedures worldwide to date, utilizing >29,000 iFuse implants. Over 700 surgeons have performed the procedures that are designed to treat dege...
BARE BONES® - December 16, 2013
Studies indicate that patients treated with SI-BONE's iFuse Implant System® to fuse the sacroiliac joint showed significantly better perioperative measures vs. those treated with open surgery. Further, early ...
BARE BONES® - November 25, 2013
Studies suggest that lifetime costs of treating appropriately-selected Medicare patients with MIS sacroiliac joint fusion may result in savings from US $660MM to $4BB vs. the lifetime costs of non-oper...
BARE BONES® - September 10, 2013
SI-BONE announced that >8,500 patients have been treated with the iFuse Implant System®, resulting in >25,000 implants placed worldwide in the treatment of sacroiliac joint pain. (
BARE BONES® - June 5, 2013
SI-BONE announced initial iFuse sacroiliac joint fusion procedures performed in Canada, Turkey and the U.K., as well as publication of postmarket surveillance safety data on the 1st 5,...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group